KTTAW
Pasithea Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+174.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.00x
- Price / sales
- —
- Price / cash flow
- -0.00x
Enterprise value
- Enterprise value
- -$45.7B
- EV / sales
- —
- EV / EBITDA
- 1959.65x
- EV / EBIT
- 1906.14x
- Market cap
- $55.1K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026